Pivampicillin (Pondocillin) in the treatment of maxillary sinusitis.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D004809:Ephedrine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008443:Maxillary Sinus / Q000382:microbiology*; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010146:Pain; D010919:Placebos; D011422:Propionates / Q000627:therapeutic use; D012852:Sinusitis / Q000188:drug therapy*; D013997:Time Factors; D014581:Urticaria / Q000139:chemically induced
D010919:Placebos; D011422:Propionates; D000667:Ampicillin; D004809:Ephedrine